Pulse Podcast | Aiding the “sniper” target a diseased cell

PT Jyothi Datta | Updated on July 17, 2021

Vav Life Sciences, a little known nanotech research company, made an “accidental” entry into making specialised lipids used in targeted drug delivery.

This has put the company in a small circle of just four global players making phospholipids, for mRNA vaccines.

Vav Life Sciences' Managing Director Arun Kedia explains the significance of targeted drug delivery, which is hailed as the medicine of tomorrow. The “silver bullet” or “sniper” approach helps deliver the medicine to the precise diseased cell. 

Edited: by Gitanjali Diwakar

Published on July 17, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.